Medicines Consent Notices




3296
NEW ZEALAND GAZETTE
No. 130

Product: Intron-A
Active Ingredient(s): Interferon alfa-2b 30MIU
Dosage Form: Powder for injection
New Zealand Sponsor: Schering-Plough Pty Limited
Manufacturer(s): Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland

Product: Intron-A
Active Ingredient(s): Interferon alfa-2b 10MIU/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Schering-Plough Pty Limited
Manufacturer(s): Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland

Product: Intron-A
Active Ingredient(s): Interferon alfa-2b 6MIU/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Schering-Plough Pty Limited
Manufacturer(s): Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland

Product: Rebeton (Combination Product)
Active Ingredient(s): Interferon alfa-2b 6MIU/mL
Dosage Form: Solution for injection
Manufacturer(s): Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland
Schering-Plough Products Inc, Las Piedras, Puerto Rico

Active Ingredient(s): Ribavirin 200mg
Dosage Form: Capsule
Manufacturer(s): Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland
Schering-Plough Products Inc, Las Piedras, Puerto Rico
New Zealand Sponsor: Schering-Plough Pty Limited

Product: Rebeton (Combination Product)
Active Ingredient(s): Interferon alfa-2b 15MIU/mL
Dosage Form: Solution for injection
Manufacturer(s): Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland
Schering-Plough Products Inc, Las Piedras, Puerto Rico

Active Ingredient(s): Ribavirin 200mg
Dosage Form: Capsule
Manufacturer(s): Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland
New Zealand Sponsor: Schering-Plough Pty Limited

Dated this 6th day of September 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go6804

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Healón 5
Active Ingredient(s): Sodium hyaluronate 5000 23mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmacia & Upjohn Limited Company
Manufacturer(s): Pharmacia & Upjohn AB, Uppsala, Sweden

Product: Miflasonе
Active Ingredient(s): Beclomethasone dipropionate 100μg
Dosage Form: Powder filled inhalation capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer(s): Pharmachemie BV, Zaandam, The Netherlands

Product: Miflasonе
Active Ingredient(s): Beclomethasone dipropionate 200μg
Dosage Form: Powder filled inhalation capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer(s): Pharmachemie BV, Zaandam, The Netherlands



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2000, No 130


Gazette.govt.nz PDF NZ Gazette 2000, No 130





✨ LLM interpretation of page content

🏥 Consent to the Distribution of Changed Medicines (continued from previous page)

🏥 Health & Social Welfare
6 September 2000
Medicines, Distribution, Interferon alfa-2b, Intron A, Schering-Plough
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
6 September 2000
Medicines, Distribution, Sodium hyaluronate, Beclomethasone dipropionate, Healón 5, Miflasonе
  • G. R. Boyd, Chief Advisor, Safety and Regulation